Other peptides with anticancer properties are peptide hormones acting on the pituitary axis in the treatment of endocrinological cancers such as breast and prostate cancer and peptides acting on neuroendocrine receptors such as somatostatin and BN/GRP (bombesin/gastrin-releasing peptide). The gene discussed is GRP; the disease is prostate carcinoma.